Veterinary Medicine Market to Reach USD 53.47 Billion by 2033 as Rising Pet Ownership and Animal Healthcare Spending Dri

The global veterinary medicine market is experiencing steady expansion, driven by increasing pet ownership, rising expenditure on animal healthcare, and growing awareness of zoonotic and chronic diseases among animals. Veterinary medicines continue to play a critical role in the prevention, diagnosis, treatment, and management of diseases across both companion and domesticated animals.

According to Straits Research analysis, the global veterinary medicine market size was valued at USD 33.88 billion in 2024. It is estimated to reach from USD 35.64 billion in 2025 to USD 53.47 billion by 2033, growing at a CAGR of 5.20% during the forecast period (2025–2033).

Base Year: 2024
Forecast Period: 2025–2033

Unlock Full Report Insights and Strategic Analysis- https://straitsresearch.com/report/veterinary-medicine-market

The growing adoption of preventive animal healthcare, increasing demand for livestock productivity, and expanding veterinary service infrastructure are expected to support long-term market growth worldwide.

Key Highlights

Largest Region: North America
Fastest Growing Region: Europe
Largest Segment by Animal Type: Domesticated (CAGR 5.99%)
Largest Segment by Product: Drugs (CAGR 4.86%)
Largest Segment by Distribution Channel: Veterinary Hospitals and Clinics (CAGR 5.60%)
Largest Segment by Route of Administration: Oral (CAGR 5.01%)

Market Dynamics

Drivers

The veterinary medicine market is primarily driven by the rising rate of pet ownership across both developed and emerging economies. Growing emotional attachment to companion animals, combined with increasing awareness regarding preventive healthcare, is encouraging pet owners to spend more on veterinary drugs, vaccines, and routine animal care. Higher disposable incomes and the growing trend of pet humanization are further strengthening demand for advanced veterinary medicines.

Another major growth driver is the increasing prevalence of zoonotic and chronic diseases in animals. Livestock and companion animals are increasingly susceptible to infectious diseases, metabolic disorders, and age-related chronic conditions. This has accelerated the adoption of veterinary pharmaceuticals, vaccines, and disease prevention programs across global animal health ecosystems.

Restraints and Opportunities

A major challenge restraining market growth is the shortage of qualified veterinarians, particularly in emerging economies. Limited access to veterinary professionals, combined with slower adoption of modern veterinary technologies in several regions, may hinder timely diagnosis and treatment of animal diseases.

However, increasing investment in veterinary hospitals and animal healthcare infrastructure is creating significant opportunities for market expansion. Growing spending by both governments and private players on veterinary clinics, diagnostic facilities, and advanced treatment capabilities is expected to improve access to animal healthcare services and support long-term industry growth.

Top Market Players

Ceva
Elanco
Chanelle Pharma Group
Dechra Pharmaceuticals plc
Norbrook Laboratories
Zoetis
Merck Animal Health
Boehringer Ingelheim
Vetoquinol S.A.

Download the Free Sample Report - https://straitsresearch.com/report/veterinary-medicine-market/request-sample

Segmentation Analysis

By Animal Type

Domesticated
Companion

By Product

Drug
Vaccines

By Route of Administration

Oral
Parental
Others

By Distribution Channel

Veterinary Hospitals and Clinics
Retail Stores
Online Pharmacies

By Region

North America
Europe
Asia-Pacific (APAC)
Middle East and Africa
Latin America (LATAM)

About Us

Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights and market research reports.